Qilu Pharmaceutical Co., Ltd. is one of the leading pharmaceutical companies in China with over 50 years of experience in the pharmaceutical industry. We specialize in developing and manufacturing a variety of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), including oncology products, anti-infectives, drugs for cerebrovascular and cardiovascular diseases, psychological diseases, and ophthalmological diseases, etc. We have various dosage forms including powder for injection, lyophilized powder for injection, liquid injection, tablets, capsules, creams, ointments, sprays, eye drops, etc. Our products are of high quality and totally safe, and are used by clinical practitioners across the world.

Product quality is vital to the growth of any manufacturer. Qilu Pharmaceutical places the highest importance on human health. Since our foundation, Qilu Pharmaceutical has been dedicated to providing our customers with reliable and safe drugs and considerate service. We guarantee our product quality by employing experienced researchers, scientists, and quality control professionals, and acquiring world-leading production equipment, testing instruments, and analytical technologies, as well as establishing quality assurance and quality control departments to oversee each manufacturing procedure. We also focus on environmental protection. We employ environmental monitoring and control measures during drug manufacturing in order to prevent any contamination.

Reducing production costs and offering competitive prices to our customers is our goal. In order to accomplish this, we've acquired production lines from Germany, America, and Italy to produce our powder for injection, injection, tablets and capsules. These imported, fully-automated production lines greatly improve production efficiency and save on labor, thus enable us to reduce our prices while guaranteeing product quality. In addition, we are located in Jinan, Shandong Province, near the East China Sea and Bohai Sea. This location provides us with lower transportation fees for our raw materials, and also saves our customers on freight charges. In addition, low-cost labor and land also allow us to offer our pharmaceuticals at lower prices without sacrificing product quality.

Strict quality control has enabled us to become a GMP certified pharmaceutical manufacturer in China, approved by the State Food and Drug Administration. Furthermore, our active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) have received certification from USFDA, EDQM, MHRA (UK), and MCC (South Africa) as well as many other drug regulatory authorities of different countries.

To be environmentally responsible, we adhere to the practice of effectively using resources while being environmentally friendly. To accomplish this, we implement the EHS policy to offer a safe and healthy environment to our employees and the society. Since 1995, we have invested more than 30 million USD in constructing waste water treatment plant to ensure that we keep our environment clean. Therefore, we can effectively handle and control all wastes produced during drug production.

As a professional pharmaceutical manufacturer in China, we have established seven manufacturing bases covering an area of 1.75 million square meters. With our vast production capacity and capability, Qilu Pharmaceutical can provide over 200 APIs and FDFs. Our drugs can be classified into the following 6 categories: Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases.